Skip to main content
. 2020 Jan 1;10(3):1319–1331. doi: 10.7150/thno.37543

Figure 7.

Figure 7

Validation of AGuIX® NP retention in tumors in human 7 days after iv injection. 3D MRI from one of the patients (NSCLC primary cancer) treated with the highest dose of AGuIX® NPs (100 mg/kg) obtained 2 h and 7 days after iv injection. The 3D MRI confirmed that SE was still detected in the brain metastases 7 days after iv injection of AGuIX® NPs.